Cargando…

Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages

Members of the Burkholderia cepacia complex are virulent, multi-drug resistant pathogens that survive and replicate intracellularly in patients with cystic fibrosis (CF). We have discovered that B. cenocepacia cannot be cleared from CF macrophages due to defective autophagy, causing continued system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrestha, Chandra L., Assani, Kaivon D., Rinehardt, Hannah, Albastroiu, Florentina, Zhang, Shuzhong, Shell, Richard, Amer, Amal O., Schlesinger, Larry S., Kopp, Benjamin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642023/ https://www.ncbi.nlm.nih.gov/pubmed/28982193 http://dx.doi.org/10.1371/journal.pone.0186169

Ejemplares similares

IFN-γ Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages
por: Assani, Kaivon, et al.
Publicado: (2014)

Correction: IFN-γ Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages
por: Assani, Kaivon, et al.
Publicado: (2019)

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
por: Zhang, Shuzhong, et al.
Publicado: (2018)

Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation
por: Ferrari, Eleonora, et al.
Publicado: (2017)

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
por: Fraser-Pitt, Douglas, et al.
Publicado: (2016)

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial
por: Devereux, Graham, et al.
Publicado: (2020)

A Breathe in Cystic Fibrosis Therapy: A New Therapeutic Endeavor for Cysteamine
por: De Stefano, Daniela, et al.
Publicado: (2015)

An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
por: Devereux, Graham, et al.
Publicado: (2016)

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
por: Charrier, Cedric, et al.
Publicado: (2014)

(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages
por: Shrestha, Chandra L., et al.
Publicado: (2020)

Characteristics of invasive Acinetobacter species isolates recovered in a pediatric academic center
por: Jain, Avish L., et al.
Publicado: (2016)

Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections
por: Durfey, Samantha L., et al.
Publicado: (2021)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis
por: Gonem, Sherif, et al.
Publicado: (2014)

CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages
por: Badr, Asmaa, et al.
Publicado: (2022)

Lung clearance index in subjects with cystic fibrosis in Italy
por: Lombardi, Enrico, et al.
Publicado: (2019)

Characterizing Mucociliary Clearance in Young Children with Cystic Fibrosis
por: Laube, Beth L., et al.
Publicado: (2022)

Tromethamine improves mucociliary clearance in cystic fibrosis pigs
por: Ash, Jamison J., et al.
Publicado: (2022)

Mechanical insufflation–exsufflation for airway clearance in adults with cystic fibrosis
por: Gaynor, Madeline, et al.
Publicado: (2018)

Applications of lung clearance index in monitoring children with cystic fibrosis
por: Fretzayas, Andrew, et al.
Publicado: (2019)

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
por: Tosco, A, et al.
Publicado: (2016)

Airway Clearance Therapy in Cystic Fibrosis Patients Insights from a Clinician Providing Cystic Fibrosis Care
por: Chaudary, Nauman, et al.
Publicado: (2021)

Not All Children with Cystic Fibrosis Have Abnormal Esophageal Neutralization during Chemical Clearance of Acid Reflux
por: Woodley, Frederick W., et al.
Publicado: (2017)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: A randomized controlled trial
por: Trimble, Aaron, et al.
Publicado: (2022)

Lung Clearance Index in Children with Cystic Fibrosis during Pulmonary Exacerbation
por: Walicka-Serzysko, Katarzyna, et al.
Publicado: (2021)

Elastic mucus strands impair mucociliary clearance in cystic fibrosis pigs
por: Pino-Argumedo, Maria I., et al.
Publicado: (2022)

Airway clearance physiotherapy and health-related quality of life in cystic fibrosis
por: Gursli, Sandra, et al.
Publicado: (2022)

Real-world effectiveness of airway clearance techniques in children with cystic fibrosis
por: Filipow, Nicole, et al.
Publicado: (2023)

Patient and Caregiver Perceptions of Airway Clearance Methods Used for Cystic Fibrosis
por: Kienenberger, Zoe E., et al.
Publicado: (2023)

Clearance of mixed biofilms of Streptococcus pneumoniae and methicillin-susceptible/resistant Staphylococcus aureus by antioxidants N-acetyl-l-cysteine and cysteamine
por: Sempere, Julio, et al.
Publicado: (2022)

Lung clearance index to characterize clinical phenotypes of children and adolescents with cystic fibrosis
por: Gambazza, Simone, et al.
Publicado: (2022)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
por: Roehmel, Jobst, et al.
Publicado: (2014)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

A monoclinic polymorph of cysteamine hydrochloride
por: Ahmad, Saeed, et al.
Publicado: (2009)

Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018)

A Review on the Antimutagenic and Anticancer Effects of Cysteamine
por: Lee, Chun-Man
Publicado: (2023)

Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
por: Klank, Sabrina, et al.
Publicado: (2023)

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
por: Devereux, Graham, et al.
Publicado: (2015)

Liquid hyper-absorption as a cause of increased DTPA clearance in the cystic fibrosis airway
por: Corcoran, Timothy E, et al.
Publicado: (2013)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2cf7nkbg415bp0mbdodlslgq1s